Cataracts; Left eye retinal detachment; Retinal detachment of lens/retina detachment; This spontaneous case was reported by a consumer and describes the occurrence of RETINAL DETACHMENT (Retinal detachment of lens/retina detachment), CATARACT (Cataracts) and RETINAL DETACHMENT (Left eye retinal detachment) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21 and 025L204) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced RETINAL DETACHMENT (Retinal detachment of lens/retina detachment) (seriousness criterion medically significant). On 14-Apr-2021, the patient experienced CATARACT (Cataracts) (seriousness criterion medically significant). 14-Apr-2021, the patient experienced RETINAL DETACHMENT (Left eye retinal detachment) (seriousness criterion medically significant). The patient was treated with Surgery for Retinal detachment and Surgery for Retinal detachment. At the time of the report, RETINAL DETACHMENT (Retinal detachment of lens/retina detachment), CATARACT (Cataracts) and RETINAL DETACHMENT (Left eye retinal detachment) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Ophthalmological examination: abnormal (abnormal) right eye.         Patient reported that after receiving the second dose of the vaccine, patient experience a retinal detachment of lens less than twenty-four hours and now have eye damage to right eye.25Feb2021, patient sawoptometrist for first eye exam to be fit for eyeglasses. Doctor discovered no issues with patient's eyes other than needing glasses.04Mar2021,patient's right eye loss of vision(clouded and obscured)in the morning by the afternoon,patient had lost more than 50 percent of vision in right eye. Patient has submitted first medical request on this day.08Mar2021,patient was seen by the LVN and they gave eye drops and sent patient back to housing.09Mar2021,patient submitted another medical request as patient's vision was not improving.12Mar2021,patient spoked with onsite doctor and patient continued to request further medical assistance.15Mar2021,patient saw doctor on site.25Mar2021, patient saw optometrist, doctor found retina detachment refuted patient to offsite private doctor.26Mar2021,Doctor examined patient's right eye and ordered eye surgery stay for 27 Mar 2021.30Mar2021, patient was released. On 29 Mar 2021,patient saw doctor and he performed laser surgery on right eye for a tear.14 Apr 2021,patient saw doctor and he diagnosed patient with left eye retinal detachment as well as cataracts developing. Patient was waiting for the medical reports as well as decisions on further treatment.Doctor has made explicit instructions for no eproxan to be administered to patient for fear of further complications.No concomitant medication was reported.   This case was linked to MOD-2022-475138 (Patient Link).; Sender's Comments: This spontaneous case concerns a male patient of an unknown age, with no medical history reported, who experienced the serious (medically significant) unexpected events of retinal detachment (captured twice as 2 separate episodes are reported) and cataract, after the administration of the second dose of the mRNA-1273 vaccine. On the following day of vaccination, the patient reported starting with loss of vision, (he was treated with unspecified eye drops with no response) and retinal detachment was diagnosed 22 days after vaccination by an optometrist. A laser surgery on his right eye was performed, and in a post-surgery consultation a retinal detachment and cataract were found in his left eye, 42 days after the second dose of vaccination. He is waiting for further treatment. After the first dose of mRNA-1273, patient consulted an optometrist, and no abnormality was detected. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.